Caris Life Sciences(CAI.US)

Last Updated 19:00:00 ET
longbridge loading

Caris Life Sciences Announces Share Repurchase Program | CAI Stock News

StockTitan·
US
CAI
+5.08%
StockTitan·
US
CAI
+5.08%

Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing | CAI Stock News

StockTitan·
US
CAI
+5.08%
US
SBIO
+2.31%
US
BBH
+0.77%
StockTitan·
US
CAI
+5.08%
US
SBIO
+2.31%
US
BBH
+0.77%

You’ve Likely Never Heard of Caris Life Sciences Stock. Billionaire Stanley Druckenmiller Has – and He Likes What He Sees.

Barchart Option·
US
CAI
+5.08%
Barchart Option·
US
CAI
+5.08%

Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek | CAI Stock News

StockTitan·
US
CAI
+5.08%
US
IHF
+1.94%
US
XBI
+2.30%
StockTitan·
US
CAI
+5.08%
US
IHF
+1.94%
US
XBI
+2.30%

A Look At Caris Life Sciences (CAI) Valuation After Recent Growth, Product Launches And Clinical Data Advances

Simplywall·
US
CAI
+5.08%
US
ARKG
+1.24%
US
IBB
+1.46%
Simplywall·
US
CAI
+5.08%
US
ARKG
+1.24%
US
IBB
+1.46%

Caris Life Sciences Eyes Bigger Oncology Market After IPO as Revenue Jumps 79%

Market Beat·
US
CAI
+5.08%
US
BBH
+0.77%
US
LABU
+6.80%
Market Beat·
US
CAI
+5.08%
US
BBH
+0.77%
US
LABU
+6.80%

Caris Life Sciences Director Purchased Shares Worth Over $501K

TradingView·
US
CAI
+5.08%
TradingView·
US
CAI
+5.08%
© 2026 Longbridge｜Disclaimer